Drawing for BERG HEALTH

USPTO serial 87039369

BERG HEALTH

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
GARTNER, JOHN M
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BERG HEALTH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lori J. Shyavitz

Lori J. Shyavitz MCCARTER & ENGLISH, LLP265 FRANKLIN STREETBOSTON, MA 02110-3113UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for use in the diagnosis, prevention, management and treatment of metabolic, viral, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, opthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related conditions, diseases and disorders; Diagnostic preparations for medical and veterinary use; Pharmaceutical preparations for wounds; Clinical medical reagents; Diagnostic kits comprising reagents for medical and clinical medical useACTIVE—
042Pharmaceutical, medical, scientific, biopharmaceutical and biotechnology research and development; Drug discovery services; Pharmaceutical and biopharmaceutical drug development services; Providing medical research and scientific research information in the field of medicine and pharmaceuticals; Medical testing for scientific research purposes in the field of metabolic condition and disease, cancer, biomarkers, endocrinology diseases, central nervous system diseases and inflammatory disorders; Medical research featuring the identification and validation of disease related biomarkers; Providing on-line, non-downloadable software applications to compile and analyze scientific and medical dataACTIVE—
044Medical and veterinary services; medical testing for diagnostic or treatment purposes; medical diagnostic, prognostic and theranostic screening and testing; medical diagnostic and theranostic monitoring and reporting services; veterinary testing for diagnostic or treatment purposes; veterinary prognostic and theranostic screening and testing; veterinary diagnostic and theranostic monitoring and reporting services; health care services, namely, providing a database of diseases and the collection of disease data and information all for treatment and diagnostic purposes; health care services, namely, providing a database in the field of patient diagnostic, admissions, discharge, transfer (ADT), electronic health records (EHR), molecular, biomarker, genomic medicine, and clinical data including medication and laboratory values with systems for output of customized knowledge and information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; patient outcome analysis services, namely, providing on-line medical record analysis services designed to provide patients with custom tailored information about the range of possible diagnoses, treatments and therapies associated with a defined set of symptoms and evaluating patient records, disease markers and environmental factors to provide patients with information about possible diagnoses, treatments and therapies; predictive modeling of data in the fields of medicine and healthcare, for medical diagnostic, prognostic and treatment purposes; providing health information; medical informationACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Apr 23, 2020MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 23, 2020ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 24, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 23, 2019EX5GSOU EXTENSION 5 GRANTED—
Sep 23, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 18, 2019EXT5SOU EXTENSION 5 FILED—
Sep 18, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 16, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 14, 2019EX4GSOU EXTENSION 4 GRANTED—
Mar 14, 2019EXT4SOU EXTENSION 4 FILED—
Mar 14, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 11, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 7, 2018EX3GSOU EXTENSION 3 GRANTED—
Sep 7, 2018EXT3SOU EXTENSION 3 FILED—
Sep 7, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 23, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 21, 2018EX2GSOU EXTENSION 2 GRANTED—
Mar 21, 2018EXT2SOU EXTENSION 2 FILED—
Mar 21, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 21, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 22, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 20, 2017EX1GSOU EXTENSION 1 GRANTED—
Sep 20, 2017EXT1SOU EXTENSION 1 FILED—
Sep 20, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 21, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 24, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 24, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 4, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 12, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 12, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Dec 12, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 12, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 12, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 9, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 8, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 8, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 8, 2016TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 8, 2016GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jun 8, 2016GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jun 8, 2016CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jun 8, 2016DOCKASSIGNED TO EXAMINER—
May 20, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 20, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance